Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
26 Aug 2013 Improved Survival in Patients with Glioblastoma Following FDA Approval of Bevacizumab Central nervous system malignancies - Anticancer agents & Biologic therapy
21 Aug 2013 Expert Highlights From the Inaugural NCCN Guideline for Penile Cancer Genitourinary cancers
20 Aug 2013 Experts Call for More Support for Tumour Biomarker Tests Personalised medicine
19 Aug 2013 The Future Development of Targeted Therapies in the Era of Genomics Personalised medicine
19 Aug 2013 Signatures of Mutational Processes in Cancer Translational research
31 Jul 2013 European Medicines Agency Recommends Granting a Marketing Authorisation for Filgrastim (Grastofil) Palliative and supportive care - Anticancer agents & Biologic therapy
30 Jul 2013 European Medicines Agency Recommends Changes to the Use of Metoclopramide Palliative and supportive care - Anticancer agents & Biologic therapy
29 Jul 2013 European Medicines Agency recommends granting a marketing authorisation for afatinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
24 Jul 2013 WINTHER Trial Aims to Offer Improved Cancer Care Personalised medicine - Anticancer agents & Biologic therapy
23 Jul 2013 Paradoxical Oncogenic Transformation Melanoma - Anticancer agents & Biologic therapy
22 Jul 2013 Radium-223 in Metastatic Prostate Cancer Genitourinary cancers - Anticancer agents & Biologic therapy
19 Jul 2013 Aflibercept in Colorectal Cancer: Indication of Minor Added Benefit Gastrointestinal cancers - Anticancer agents & Biologic therapy
16 Jul 2013 FDA Approves Afatinib for the First Line Treatment of Patients with Metastatic NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
15 Jul 2013 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Panitumumab Gastrointestinal cancers - Anticancer agents & Biologic therapy
09 Jul 2013 The European Medicines Agency Extends Indications for Lapatinib Breast cancer - Anticancer agents & Biologic therapy